Blood test guides custom ALS supplements in new pilot study
NCT ID NCT06429059
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 29 times
Summary
This pilot study tested whether a blood test could help choose personalized supplements for people with ALS. 50 participants were grouped into four categories based on their blood work and received a specific supplement for 6 months. The goal was to see if this approach could slow the progression of ALS. The study was completed at Duke University.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
-
Temple University
Philadelphia, Pennsylvania, 19122, United States
Conditions
Explore the condition pages connected to this study.